BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27342845)

  • 1. Constitutive CD40 Signaling Calibrates Differentiation Outcomes in Responding B Cells via Multiple Molecular Pathways.
    Basu S; Kaw S; D'Souza L; Vaidya T; Bal V; Rath S; George A
    J Immunol; 2016 Aug; 197(3):761-70. PubMed ID: 27342845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular B Cells Promote Atherosclerosis via T Cell-Mediated Differentiation Into Plasma Cells and Secreting Pathogenic Immunoglobulin G.
    Tay C; Liu YH; Kanellakis P; Kallies A; Li Y; Cao A; Hosseini H; Tipping P; Toh BH; Bobik A; Kyaw T
    Arterioscler Thromb Vasc Biol; 2018 May; 38(5):e71-e84. PubMed ID: 29599140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blimp-1 over-expression abrogates IL-4- and CD40-mediated suppression of terminal B cell differentiation but arrests isotype switching.
    Knödel M; Kuss AW; Berberich I; Schimpl A
    Eur J Immunol; 2001 Jul; 31(7):1972-80. PubMed ID: 11449349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role for c-fos/activator protein 1 in B lymphocyte terminal differentiation.
    Ohkubo Y; Arima M; Arguni E; Okada S; Yamashita K; Asari S; Obata S; Sakamoto A; Hatano M; O-Wang J; Ebara M; Saisho H; Tokuhisa T
    J Immunol; 2005 Jun; 174(12):7703-10. PubMed ID: 15944271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential involvement of the transcription factor Blimp-1 in T cell-independent and -dependent B cell differentiation to plasma cells.
    Soro PG; Morales-A P; Martínez-M JA; Morales-A S; Copín SG; Marcos MA; Gaspar ML
    J Immunol; 1999 Jul; 163(2):611-7. PubMed ID: 10395648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arrest of B lymphocyte terminal differentiation by CD40 signaling: mechanism for lack of antibody-secreting cells in germinal centers.
    Randall TD; Heath AW; Santos-Argumedo L; Howard MC; Weissman IL; Lund FE
    Immunity; 1998 Jun; 8(6):733-42. PubMed ID: 9655487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERKs induce expression of the transcriptional repressor Blimp-1 and subsequent plasma cell differentiation.
    Yasuda T; Kometani K; Takahashi N; Imai Y; Aiba Y; Kurosaki T
    Sci Signal; 2011 Apr; 4(169):ra25. PubMed ID: 21505187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bim regulates B-cell receptor-mediated apoptosis in the presence of CD40 signaling in CD40-pre-activated splenic B cells differentiating into plasma cells.
    Gao Y; Kazama H; Yonehara S
    Int Immunol; 2012 May; 24(5):283-92. PubMed ID: 22301689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligation of CD27 on murine B cells responding to T-dependent and T-independent stimuli inhibits the generation of plasma cells.
    Raman VS; Bal V; Rath S; George A
    J Immunol; 2000 Dec; 165(12):6809-15. PubMed ID: 11120803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemokinin-1 activates the MAPK pathway and enhances B cell proliferation and antibody production.
    Wang W; Li Q; Zhang J; Wu H; Yin Y; Ge Q; Zhang Y
    J Immunol; 2010 Apr; 184(7):3590-7. PubMed ID: 20208012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blimp-1 siRNA inhibits B cell differentiation and prevents the development of lupus in mice.
    Zhou Z; Li A; Wang Z; Pei F; Xia Q; Liu G; Ren Y; Hu Z
    Hum Immunol; 2013 Mar; 74(3):297-301. PubMed ID: 23220434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor 9, transmembrane activator and calcium-modulating cyclophilin ligand interactor, and CD40 synergize in causing B-cell activation.
    Ozcan E; Rauter I; Garibyan L; Dillon SR; Geha RS
    J Allergy Clin Immunol; 2011 Sep; 128(3):601-9.e1-4. PubMed ID: 21741080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo.
    Angelin-Duclos C; Cattoretti G; Lin KI; Calame K
    J Immunol; 2000 Nov; 165(10):5462-71. PubMed ID: 11067898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiation of plasma-cell differentiation is independent of the transcription factor Blimp-1.
    Kallies A; Hasbold J; Fairfax K; Pridans C; Emslie D; McKenzie BS; Lew AM; Corcoran LM; Hodgkin PD; Tarlinton DM; Nutt SL
    Immunity; 2007 May; 26(5):555-66. PubMed ID: 17509907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell receptor signal strength influences terminal differentiation.
    Lechouane F; Bonaud A; Delpy L; Casola S; Oruc Z; Chemin G; Cogné M; Sirac C
    Eur J Immunol; 2013 Mar; 43(3):619-28. PubMed ID: 23280426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
    White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
    J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD28 Promotes Plasma Cell Survival, Sustained Antibody Responses, and BLIMP-1 Upregulation through Its Distal PYAP Proline Motif.
    Rozanski CH; Utley A; Carlson LM; Farren MR; Murray M; Russell LM; Nair JR; Yang Z; Brady W; Garrett-Sinha LA; Schoenberger SP; Green JM; Boise LH; Lee KP
    J Immunol; 2015 May; 194(10):4717-28. PubMed ID: 25833397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
    Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
    Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD40 signaling drives B lymphocytes into an intermediate memory-like state, poised between naïve and plasma cells.
    Upadhyay M; Priya GK; Ramesh P; Madhavi MB; Rath S; Bal V; George A; Vaidya T
    J Cell Physiol; 2014 Oct; 229(10):1387-96. PubMed ID: 24482285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RP105/MD-1 complex is indispensable for TLR4/MD-2-dependent proliferation and IgM-secreting plasma cell differentiation of marginal zone B cells.
    Nagai Y; Yanagibashi T; Watanabe Y; Ikutani M; Kariyone A; Ohta S; Hirai Y; Kimoto M; Miyake K; Takatsu K
    Int Immunol; 2012 Jun; 24(6):389-400. PubMed ID: 22354914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.